Matthew Kisielius
About Matthew Kisielius
Matthew Kisielius is the Associate Director of Drug Product Lifecycle Management at Bristol Myers Squibb, specializing in Parenteral Manufacturing Science & Technology.
Title and Current Role
Matthew Kisielius is currently the Associate Director, Drug Product Lifecycle Management; Parenteral Manufacturing Science & Technology at Bristol Myers Squibb in New Brunswick, New Jersey, United States. In this role, he leads the technical agenda for a major biologics brand, including various presentations and delivery devices. Kisielius also contributes to the strategic technology roadmap for parenteral manufacturing in partnership with other matrix technical teams and multi-functional stakeholders.
Professional Experience at Bristol Myers Squibb
Before becoming the Associate Director at Bristol Myers Squibb, Matthew Kisielius worked as a Principal Engineer from 2017 to 2021 in New Brunswick, NJ. During his tenure, he was accountable for life cycle management for multiple products and the development of new technology for optimization and continuous improvement in manufacturing operations. He was responsible for technology transfer to both internal and external sites, providing specialized expertise as necessary to complement site capabilities for critical investigations or process improvements.
Professional Experience at Merck
Matthew Kisielius has extensive experience at Merck, serving in various positions over a span of several years. He worked as a Senior Specialist in Engineering - Technical Services - Barrier Operations from 2016 to 2017 and as an Engineering Specialist in the same department from 2014 to 2016 in West Point, PA. Prior to that, he held roles such as Engineering Specialist in West Point Project Management & Execution in 2013-2014, Engineering Specialist in Sterile Supply Technical Operations from 2011 to 2013, and Engineer - Lead Investigator in Sterile Supply Technical Operations from 2009 to 2011. In these roles, he contributed significantly to process improvements and technical services.
Educational Background
Matthew Kisielius studied at Drexel University, where he earned a Bachelor of Science in Chemical Engineering. He attended the university from 2004 to 2009, giving him a strong foundation in engineering principles that he has applied throughout his career in the pharmaceutical and biopharmaceutical sectors.